Trials / Recruiting
RecruitingNCT06863649
Short-term Effect of Using Non-immersive Gamified Exercises on Chronic Pain in People With Stroke.
Measuring Biomarkers for Health in Community Environments: eMBraCE Activity Program; Short Term Effect of Using Non-immersive Gamified Exercises on Chronic Shoulder Pain in People With Chronic Stroke.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- University of Exeter · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Rehabilitation after stroke is essential to minimize permanent disability. Gamification of exercises has emerged as a promising strategy for increasing motivation and rehabilitation efficacy in people with stroke. However, there is a gap in understanding how exercise gamification can aid in pain management among people with stroke who are experiencing shoulder pain difficulties. This study aims to evaluate the short-term effect of using gamified non-immersive exercises on shoulder pain level, upper limb range of motion, and shoulder and elbow muscle activities while doing different activities in people with chronic stroke. The study will be conducted using an observational study design. Various lab assessments include measuring the ROM of the shoulder (MOCAP), EMG, FNIRS, pain intensity using VAS scale, and muscles activities patterns across upper limb joints.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Gamified NON-IMMERSIVE VIRTUAL REALITY EXERCISES | The game phase lasts for 2 minutes. These targets are challenging for the participant. |
| OTHER | video-based exercises | The participant will exercise by replicating the exercises demonstrated in a 2-minute video, recorded with the same movement patterns that they will find in the gamified intervention. |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2025-07-01
- Completion
- 2025-09-01
- First posted
- 2025-03-07
- Last updated
- 2025-04-16
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06863649. Inclusion in this directory is not an endorsement.